Presenilin Regulates Insulin Signaling via a γ-Secretase-independent Mechanism

Presenilin ( PS), a causative molecule of familial Alzheimer disease, acts as a crucial component of the gamma-secretase complex, which is required to cleave type I transmembrane proteins such as amyloid precursor protein and Notch. However, it also functions through gamma-secretase-independent pathways. Recent reports suggested that PS could regulate the expression level of cell surface receptors, including the PDGF and EGF receptors, followed by modulating their downstream pathways via gamma-secretase-independent mechanisms. The main purpose of this study was to clarify the effect of PS on expression of the insulin receptor (IR) as well as on insulin signaling. Here, we demonstrate that PS inhibited IR transcription and reduced IR expression, and this was followed by down-regulation of insulin signaling. Moreover, we suggest that neither gamma-secretase activity nor Wnt/beta-catenin signaling can reduce the expression of IR, but a PS-mediated increase in the intracellular Ca2+ level can be associated with it. These results clearly indicate that PS can functionally regulate insulin signaling by controlling IR expression.